Scientists pinpoint protein molecule that the body uses to detect parasitic infections
Researchers at Yale, in collaboration with National Institutes of Health researchers, have identified a specific protein molecule that is used by the immune system to detect parasitic infections, leading the way for development of future vaccines to combat these infections.
Published in the April 28 issue of Science Express, the study provides insight into understanding how infectious parasites interface with the immune system -- a problem widely considered of great scientific and clinical importance.
Most infections are caused by bacterial or viral microorganisms that produce molecules quite different from those produced by humans and other eukaryotic organisms. When microorganisms infect humans, the atypical molecules are usually detected immediately by human proteins called Toll-like receptors (TLR) that alert the human immune system to fight the infection.
But parasites, like humans, are eukaryotic in origin and how the body detects them has been a mystery.
The common parasite Toxoplasma gondii (T. gondii), which causes toxoplasmosis, has a complicated life cycle in which it is transmitted from mice to cats and then to humans. Previous research had shown that T. gondii is recognized by a TLR and that the recognition of this parasite is crucial for an appropriate immune response. However, it was unclear which of the 13 different TLRs present in mammals was responsible and which molecule of T. gondii was being recognized by the TLRs.
"In this study we found that the recognition of T. gondii by the innate immune system is mediated by a new member of the TLR family, TLR 11, that we discovered last year," says Dr. Sankar Ghosh, professor of immunobiology at the School of Medicine.
Ghosh says that although parasitic infections are less prominent in the United States than bacterial and viral infections, the global impact of parasitic infections on health is tremendous.
"Insight obtained from these studies should lead to development of novel strategies to combat these infections," he says.
Other authors from Yale are Dr. Dekai Zhang, Matthew S. Hayden, Fayyaz S. Sutterwala and Dr. Richard A. Flavell.
The research was funded by the National Institutes of Health.
-- By Karen Peart
T H I SW E E K ' SS T O R I E S
Renowned Harvard scholar named dean of Yale SOM
YALE LIBRARY NEWS
MEDICAL SCHOOL NEWS
IN MEMORIAM
|